Cardiovascular ultrasound system uses sound waves to produce live images of the heart. The global cardiovascular ultrasound system market report has been segmented on the basis of product, technology, device display, end user, and region.
Increasing prevalence of cardiovascular diseases is a major factor expected to propel the growth of the cardiovascular ultrasound system market over the forecast period. Technological advancements in cardiovascular ultrasound system by manufacturers is other factor expected to support the growth of the global cardiovascular ultrasound system market over the forecast period. However, lack of reimbursement for this system is major factor expected to limit the growth of the market.
Based on technology, the global cardiovascular ultrasound system market is segmented based on 2D, 3D and 4D, and Doppler imaging. The 3D and 4D segment is expected to register highest growth rate over the forecast period as it requires short scanning time and provides better image resolution.
Request Sample Copy of the Report: https://marketresearch.biz/report/cardiovascular-ultrasound-system-market/request-sample/
Regional segmentation includes North America, Europe, Latin America, Asia Pacific and Middle East and Africa. Europe contributes major market share and expected to maintain its dominance over the forecast period owing preference on non-invasive diagnostic procedure in the region. Asia Pacific region is expected to witness rapid growth rate over the forecast period. Countries like India, China is expected to support the growth of Asia Pacific market, owing to increasing number cases of cardiovascular diseases in near future coupled with rising awareness regarding non-invasive diagnostic procedures in the region.
Some prominent players in the global cardiovascular ultrasound system market are General Electric Company, Philips Healthcare, Siemens Healthcare, Hitachi Medical Corporation, Toshiba Medical Systems Corporation, Mindray Medical International Limited, Samsung Electronics Co., Ltd., Fujifilm Holdings Corporation, Esaote S.P.A., and Chison Medical Imaging Co., Ltd.